Real-World Use of Botulinum Neurotoxin Type A in Post-Stroke Spasticity Between 2015 and 2023: Insights From France

Authors

Institutions

Publication Details

Journal
Toxicon
Published
2026-01-08
DOI
https://doi.org/10.1016/j.toxicon.2025.108692
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Use of Botulinum Neurotoxin Type A in Post-Stroke Spasticity Between 2015 and 2023: Insights From France

Pierre Karam, Anne Forestier, Djamel Bensmaïl, Jean-Yves Loze
Toxicon
Botulinum Toxin and Related Neurological Disorders
article

Real-World Use of Botulinum Neurotoxin Type A in Post-Stroke Spasticity Between 2015 and 2023: Insights From France

Pierre Karam, Anne Forestier, Djamel Bensmaïl, Jean-Yves Loze
article en

Abstract

No abstract available for this paper.
ToxiconVol. 271
Ipsen (France) (FR), Université de Versailles Saint-Quentin-en-Yvelines (FR), Hôpital Raymond-Poincaré (FR)
Zero hunger
Openalex Percentile: Top 94%
Botulinum Toxin and Related Neurological Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-World Use of Botulinum Neurotoxin Type A in Post-Stroke Spasticity Between 2015 and 2023: Insights From France — Pierre Karam, Anne Forestier, et al. · Toxicon (2026) | TGRS Research Map | TGRS